Pharmaceutical counterfeiting

Analyst

Volumn 130, Issue 3, 2005, Pages 271-279

  Deisingh, Anil K ^a,b,c,d,e  

^a UNIVERSITY OF THE WEST INDIES   (Trinidad and Tobago)

^b LOUGHBOROUGH UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF MASSACHUSETTS   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e Caribbean Industrial Research Institute Trinidad and Tobago   (Trinidad and Tobago)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIALLERGIC AGENT; ANTIASTHMATIC AGENT; ANTIBIOTIC AGENT; ANTIMALARIAL AGENT; ANTIPYRETIC AGENT; COMBIRON; FEMME; FERROUS SULFATE; HORMONE; LEVOFLOXACIN; METHYLDOPA; METHYLPHENIDATE; PARACETAMOL; PHENTERMINE RESIN; SIBUTRAMINE; SILDENAFIL; STEROID; TADALAFIL;

CONSUMER; DRUG LABELING; DRUG LEGISLATION; DRUG MANUFACTURE; DRUG MARKETING; FORGERY; GAS CHROMATOGRAPHY; GOVERNMENT; HEALTH CARE ORGANIZATION; MASS SPECTROMETRY; NEAR INFRARED SPECTROSCOPY; POSTMARKETING SURVEILLANCE; RAMAN SPECTROMETRY; REVIEW;

EID: 15244339395     PISSN: 00032654     EISSN: None     Source Type: Journal    
DOI: 10.1039/b407759h     Document Type: Review

References (55)

1. http://www.who.int/medicines/organization.gsm/activities/ quality_assurance/cft/counterfeit.
2. http://www.fda.gov/oc/mitiatives/counterfeit/qa.html.
3. C. Clark, Pharm. J., 2003, 271, 453.
4. German Pharma Health Fund, http://www.gphf.org/web_en/projekte/minilab/ hintergrund-arzneimittelfaelschungen.htm.
5. B. Hileman, Chem. Eng. News, 2003, 36.
6. Counterfeit Pharmaceuticals Digest, issue 3, Autumn 2004, pp. 1, 5, London, CIB Counterfeit Pharmaceuticals Initiative.
7. F. Silva, Phuture, 2003, 7, 3.
8. E. Wondemagegnehu, Pharmaceutical Counterfeiting: A WHO Perspective, in Pharmaceutical Fraud and Counterfeiting, SMI Conference Documentation, London, SMI Publishing, 2003.
9. ICC Commercial Crime Services, http://www.iccwbo.org/ccs/news_archives/ 2003/counterfeit_drugs.asp, 2003.
10. A. Scheer, http://www.abnh.com/security/Pharm_WhitePaper_WEBSITE.pdf, 2003.
11. M. D. Green, P. Newton, F. Fernandez, R. Wirtz and H. Nettey, Simple low-cost strategies to rapidly identify counterfeit drugs in developing countries, in Combating Pharmaceutical Fraud and Counterfeiting, SMI Conference Documentation, London, SMI Publishing, 2003.
12. J. Bassett, R. C. Denney, G. H. Jeffery and J. Mendham, Vogel's Textbook of Quantitative Inorganic Analysis, London, Longman, 4th edn., 1978, pp. 693-696.
13. P. Newton, S. Proux, M. Green, F. Smithius, N. Phu, J. Rozendaal, S. Prakongpan, K. Chotivanich, M. Mayxay, F. Noslen and N. White, Lancet, 2001, 357, 1948.
14. M. D. Green, D. L. Mount, R. A. Wirtz and N. J. White, J. Pharm. Biomed. Anal., 2000, 24, 65.
15. http://www.gphf.org/web_en/projekte/minilab/index.htm, 2003.
16. R. Jahnke, The GPHF-Minilab Project, in Combating Pharmaceutical Fraud and Counterfeiting, SMI Conference Documentation, London, SMI Publishing, 2003.
17. G. Phillips, Pharm. J., 2003, 271, 465.
18. P. Pachaly and W. Schick, Pharm. Ind., 1993, 55, 3, 259-267.
19. B. W. Hadzija and A. M. Mattocks, Forensic Sci. Int., 1983, 23, 143-147.
20. C. L. Flurer and K. A. Wolnik, J. Chromatogr. A, 1994, 674, 1-2, 153-163.
21. Microgram Bulletin, June 2004, http://www.usdoj.gov/dea/programs/ forensicsci/microgram/mg0604/mg0604.html (13th August 2004).
22. Microgram Bulletin, April 2004, http://www.usdoj.gov/dea/programs/ forenscisci/microgram.mg0404/rng0404.htrnl (9th August 2004).
23. K. J. Mulligan, T. W. Brueggemeyer, D. F. Crockett and J. B. Schepman, J. Chromatogr. B, 1996, 686, 85-95.
24. A. Belu, S. Bryan, M. C. Davies and N. Patel, Secondary Ion Mass Spectrometry, SIMS XII, Proceedings of the International Conference on Secondary Ion Mass Spectrometry, Brussels, September 5-10 1999, 2000, pp. 919-922.
25. T. Decaestecker, K. Clauwaert, J. Van Bocxlaer, W. Lambert, E. Van den Eeckhout, C. Van Peteghem and A. De Leenheer, Adv. Mass Spectrom., 2001, 15, 377-378.
26. H. Shen, J. F. Carter, R. G. Brereton and C. Eckers, Analyst, 2003, 128, 287.
27. K. E. Arthur, J.-C. Wolff and D. J. Carrier, Rapid Commun. Mass Spectrom., 2004, 18, 6, 678-684.
28. J.-C. Wolff, L. A. Thompson and C. Eckers, Rapid Commun. Mass Spectrom., 2003, 17, 3, 215-221.
29. R. J. H. Waddell, N. NicDaeid and D. Littlejohn, Analyst, 2004, 129, 235-240.
30. D. A. Skoog and J. J. Leary, Infrared Absorption Spectroscopy, in Principles of Instrumental Analysis, Saunders, Philadelphia, 4th edn., 1992, pp. 252-289.
31. F. Gonzalez and R. Pous, J. Pharm. Biomed. Anal., 1995, 10, 419.
32. M. Blanco, J. Coello, H. Iturriaga, S. Maspoch and C. de la Pezuela, Analyst, 1997, 122, 761.
33. S. H. F. Scafi and C. Pasquini, Analyst, 2001, 126, 2218.
34. J. J. Workman, Appl. Spectrosc., 1996, 31, 251.
35. F. C. Clarke, S. V. Hammond, R. D. Jee and A. C. Moffat, Appl. Spectrosc., 2002, 56, 1475.
36. Perkin Elmer http://las.perkinelmer.com/content/applicationnotes/ 006832_01.pdf.
37. D. A. Skoog and J. J. Leary, Raman Spectroscopy, in Principles of Instrumental Analysis. Saunders, Philadelphia, 4th edn., 1992, p. 297.
38. C. M. Hodses and J. Akhavan, Spectrochim. Acta, Part A, 1990, 46, 303.
39. A. G. Ryder, G. M. O'Connor and T. J. Glynn, J. Forensic Sci., 1999, 44, 1013.
40. S. E. J. Bell, D. T. Burns, A. C. Dennis, L. J. Matchett and J. E. Speers, Analyst, 2000, 125, 1811.
41. S. Bell, D. Burns, A. Dennis and J. Speers, Analyst, 2000, 125, 541.
42. S. E. J. Bell, L. J. Barrett, D. T. Burns, A. C. Dennis and S. J. Speers, Analyst, 2003, 128, 1331.
43. B. O'Rourke, Irish Scientist, http://www.irishscientist.ie/2002/contents. asp?contentxml=02p996xml&contentxsl=ls02p.
44. http://www.molecularisotopes.com/pharm.html, 2004.
45. J. P. Jasper, Fire Arson Invest., 2002, 51, 2, 30.
46. J. P. Jasper, J. S. Edwards, L. C. Ford, R. A. Corry, F. Fourel and A. Eaton, Abstract, International Technical Working Group on Fire and Explosives, 2002, Orlando, Florida.
47. R. Jotcham, Understanding and Evaluating Security Technologies for Pharmaceuticals, in Combating Pharmaceutical Fraud and Counterfeiting, SMI Conference Documentation, London, SMI Publishing, 2003.
48. J. Prebble, Thieves take the wrap, http://www.piranet.com/admin/_private/ TechnicalArticles/00126.pdf, 2003.
49. http://www.holoprotec.com, 2004.
50. http://www.findarticles.com/cf_dls/mOEIN/2003_Oct_17/108987951/pl/ article.html, 2003.
51. A. Shanley, Drug Makers Strike Back, http://www.pharmamanufacturing.com/ Web_First/PhM.nsf/ArticleID/ASHY-5TAPDX, 2003.
52. http://www.fda.gov/oc/initiatives/counterfeit/backgrounder.html, 2003.
53. http://www.sun.com/smi/Press/sunflash/2004-02/sunflash.20040219.2.html, 2004.
54. http://www.fda.gov/oc.initiatives/counterfeit/report02_04.html.
55. P. Lowe, Fighting the Problem: The ICC's new counterfeit pharmaceuticals initiative, in Combating Pharmaceutical Fraud and Counterfeiting, SMI Conference Documentation, London, SMI Publishing, 2003.